Please note that while B12 shots can provide these benefits, they are typically recommended for individuals who have a severe deficiency or difficulty absorbing the vitamins

These lawsuits assert legal theories, including: Trademark infringement Violating the corporate practice of medicine doctrine False advertising Unfair competition Violations of federal drug laws (misbranding, unapproved new drugs) FDA Enforcement On February 6, 2026, FDA announced its intent to use all available compliance and enforcement tools within its authorities to address unsubstantiated claims and associated public health concerns. The FDA explicitly announced steps to combat compounding pharmacies making these marketing claims: Compounded products are generic versions of FDA-approved drugs Compounded products are the same as FDA-approved drugs Compounded products use the same active ingredient as FDA-approved drugs Compounded products are clinically proven to produce results FDA has made clear that failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction. This means the agency may bypass traditional warning letter procedures

Clinical research milestones for semaglutide weight loss Clinical research provides a clear, data-backed semaglutide weight loss timeline
Some users feel hungry right after a meal
FAQ What Type of Professional Liability Coverage Should Medspas Review Before Offering GLP-1 Programs
Regulation of energy metabolism by long-chain fatty acids